Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3731037
Max Phase: Preclinical
Molecular Formula: C16H30O
Molecular Weight: 238.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3731037
Max Phase: Preclinical
Molecular Formula: C16H30O
Molecular Weight: 238.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CCCCCCCCCCCCC(=O)C1
Standard InChI: InChI=1S/C16H30O/c1-15-12-10-8-6-4-2-3-5-7-9-11-13-16(17)14-15/h15H,2-14H2,1H3/t15-/m1/s1
Standard InChI Key: ALHUZKCOMYUFRB-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 238.41 | Molecular Weight (Monoisotopic): 238.2297 | AlogP: 5.28 | #Rotatable Bonds: 0 |
Polar Surface Area: 17.07 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.78 | CX LogD: 5.78 |
Aromatic Rings: 0 | Heavy Atoms: 17 | QED Weighted: 0.56 | Np Likeness Score: 0.50 |
1. (2013) Agent for inhibiting odor of pyrazine derivatives, |
Source(1):